Fatema Kaniz, Barrott Jared J
Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID, USA.
Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID, USA.
Transl Oncol. 2022 Jan;15(1):101271. doi: 10.1016/j.tranon.2021.101271. Epub 2021 Nov 18.
Osteosarcoma is a genetically complex cancer, thus there are increasing efforts to identify biomarkers and regulators within the epigenome that can better predict patient outcomes and provide new therapeutic targets. In this commentary, we have evaluated the work of Peng and colleagues on the identification and function of the signaling axis circ_0088212/miR_520 h/APOA1 in osteosarcoma. We provide the context of how novel it is to demonstrate the anti-tumor functions of APOA1 and not just correlative gene expression with patient outcome. We further postulate why some studies involving circRNAs in osteosarcoma contradict one another. We conclude that the study performed by Peng and colleagues was performed with enough rigor to give confidence that circ_0088212 is a bona fide tumor suppressor in osteosarcoma.
骨肉瘤是一种基因复杂的癌症,因此人们越来越努力地在表观基因组中识别生物标志物和调节因子,以便更好地预测患者的预后并提供新的治疗靶点。在这篇评论中,我们评估了彭及其同事关于骨肉瘤中信号轴circ_0088212/miR_520h/APOA1的鉴定和功能的研究。我们阐述了证明APOA1的抗肿瘤功能而非仅仅将基因表达与患者预后相关联的新颖之处。我们进一步推测了为什么一些涉及骨肉瘤中环状RNA的研究相互矛盾。我们得出结论,彭及其同事所进行的研究足够严谨,足以让人相信circ_0088212是骨肉瘤中一种真正的肿瘤抑制因子。